Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 4
2007 2
2008 2
2010 6
2011 1
2012 5
2013 2
2014 10
2015 6
2016 10
2017 12
2018 16
2019 7
2020 8
2021 7
2022 8
2023 5
2024 5
2025 8
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
HER-2 gene alterations as biomarker in patients with metastatic colorectal cancer treated with FOLFIRI + cetuximab: findings from the CAPRI-2 GOIM study.
Ciardiello D, Boscolo Bielo L, Napolitano S, Martinelli E, Troiani T, Cioli E, Latiano TP, Maiello E, Parente P, Avallone A, De Stefano A, Bordonaro R, Russo AE, Lotesoriere C, Vallarelli S, Pisconti S, Nisi C, Tamburini E, Viola MG, Lonardi S, Cremolini C, Iacono D, Tagliaferri P, Pietrantonio F, Tortora G, Rosati G, Zampino MG, Curigliano G, Febbraro A, Normanno N, De Vita F, Fazio N, Ciardiello F, Martini G. Ciardiello D, et al. Among authors: pisconti s. ESMO Gastrointest Oncol. 2026 Jan 19;11:100295. doi: 10.1016/j.esmogo.2025.100295. eCollection 2026 Mar. ESMO Gastrointest Oncol. 2026. PMID: 41994018 Free PMC article.
Nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil for metastatic pancreatic ductal adenocarcinoma following gemcitabine-based therapy. A systematic review and meta-analysis of randomized controlled trials.
Vitale E, Rizzo A, Maistrello L, Sciacovelli AM, De Luca R, Albano A, Fanizzi A, Massafra R, Lotesoriere C, Gadaleta-Caldarola G, Pisconti S, Brunetti O. Vitale E, et al. Among authors: pisconti s. Clin Exp Metastasis. 2026 Mar 31;43(2):21. doi: 10.1007/s10585-026-10401-5. Clin Exp Metastasis. 2026. PMID: 41915263
Validity and responsiveness of patient-reported outcomes common terminology criteria for adverse events (PRO-CTCAE) among Italian lung cancer patients.
Iacovino ML, Arenare L, Morabito A, Tiseo M, Antonuzzo A, Pisconti S, Torre SD, Anselmi E, Rossi M, Giovanardi F, Bollina R, Zanelli F, Galetta D, Leo S, Bilancia D, Biscaldi E, Manzo A, Camisa R, Montanino A, Sforza V, Stefanelli P, Gargiulo P, Piccirillo MC, Maglietta G, Iannelli E, Caminiti C, Maiello E, Pinto C, Perrone F. Iacovino ML, et al. Among authors: pisconti s. Lung Cancer. 2026 Apr;214:109312. doi: 10.1016/j.lungcan.2026.109312. Epub 2026 Feb 8. Lung Cancer. 2026. PMID: 41671908 Free article.
Cervical Cancer Complexity: Exploring the Coexistence of CIN3 and Glandular Lesions.
Guidobaldi L, Cafiero C, Stillitano G, Ricciardi E, Coppola L, Perfetti A, Colacicco M, Santacroce L, Palmirotta R, Pisconti S. Guidobaldi L, et al. Among authors: pisconti s. Infect Disord Drug Targets. 2026 Jan 29. doi: 10.2174/0118715265414137251106123730. Online ahead of print. Infect Disord Drug Targets. 2026. PMID: 41620919
APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer.
Prelaj A, Provenzano L, Miskovic V, Ganzinelli M, Mazzeo L, Gemelli M, Silvestri C, Spagnoletti A, Romanò R, Brambilla M, Occhipinti M, Beninato T, Ambrosini P, Sottotetti E, Favali M, Zec A, Ferrarin A, Corrao G, Prina MM, Ruggirello M, Marino MB, Dumitrascu AD, Di Mauro RM, Giani C, Cavalli C, Serino R, Catania C, Panzardi A, Metro G, Bennati C, Ferrara R, Macerelli M, Servetto A, Cona MS, La Verde N, Toschi L, Baili P, Corso F, Zito E, Cinieri S, Berardi R, Scoazec G, Inno A, Gori S, Pisconti S, Buzzacchino F, Brighenti M, Biello F, Tartarone A, Pruneri G, Belfiore A, Agnelli L, Guidi A, Invernizzi L, Salmistraro N, Filippi AR, Solli P, Galli G, Lorenzini D, Pizzutilo EG, De Braud F, Pedrocchi A, Trovò F, Genova C, Corte CMD, Viscardi G, Garassino MC, Cortellini A, Mingo E, Russano M, Signorelli D, Proto C, Vingiani A, Sangaletti S, Lo Russo G; APOLLO11 study group. Prelaj A, et al. Among authors: pisconti s. NPJ Precis Oncol. 2026 Jan 29;10(1):96. doi: 10.1038/s41698-026-01295-3. NPJ Precis Oncol. 2026. PMID: 41611893 Free PMC article.
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.
Ciardiello D, Martini G, Boscolo Bielo L, Pietrantonio F, Raimondi A, Manca P, Pisconti S, Nisi C, Tortora G, Salvatore L, Sartore-Bianchi A, Siena S, Blasi L, Ongaro E, Zaniboni A, Pinto C, Antonuzzo L, Avallone A, Normanno N, Santabarbara G, Zampino MG, Berardi R, Cogoni A, Lotesoriere C, Latiano TP, Maiello E, Fazio N, Curigliano G, Bordonaro R, Troiani T, De Vita F, Martinelli E, Ciardiello F, Napolitano S; CAVE-2 GOIM study group. Ciardiello D, et al. Among authors: pisconti s. Ann Oncol. 2026 May;37(5):675-685. doi: 10.1016/j.annonc.2025.12.014. Epub 2025 Dec 22. Ann Oncol. 2026. PMID: 41443411 Free article. Clinical Trial.
Genomic profiling of high tumor mutational load in microsatellite-stable colorectal cancer uncovers MAPK signaling pathway alterations following anti-EGFR therapy.
Boscolo Bielo L, Napolitano S, Avallone A, Pietrantonio F, Bordonaro R, Maiello E, Pisconti S, Tamburini E, Lotesoriere C, Tortora G, Zaniboni A, Blasi L, Antonuzzo L, Berardi R, Tagliaferri P, Cremolini C, Lonardi S, Garufi C, Pinto C, Ongaro E, Santabarbara G, Scartozzi M, De Falco V, De Stefano A, Cardone C, Iacovucci A, Bosco MF, Russo AE, Latiano TP, Nisi C, Messina M, Salmistraro N, Sartore-Bianchi A, Siena S, Zampino MG, Fazio N, Normanno N, Febbraro A, Guerrera LP, Parente P, De Vita F, Martinelli E, Troiani T, Curigliano G, Ciardiello F, Martini G, Ciardiello D. Boscolo Bielo L, et al. Among authors: pisconti s. ESMO Open. 2025 Nov;10(11):105877. doi: 10.1016/j.esmoop.2025.105877. Epub 2025 Oct 28. ESMO Open. 2025. PMID: 41161130 Free PMC article.
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.
Arenare L, Porta C, Barberio D, Terzolo S, Zagonel V, Pisconti S, Del Mastro L, Pinto C, Bilancia D, Cinieri S, Rizzo M, Migliaccio G, Montesarchio V, Del Campo L, De Lorenzo F, Iannellil E, Gitto L, Vaccaro CM, Frontini L, Giannarelli D, Bryce J, Iacovino ML, Piccirillo MC, Jommi C, Efficace F, Riva S, Di Maio M, Gallo C, Perrone F. Arenare L, et al. Among authors: pisconti s. J Cancer Policy. 2025 Dec;46:100645. doi: 10.1016/j.jcpo.2025.100645. Epub 2025 Oct 4. J Cancer Policy. 2025. PMID: 41052598 Free article.
Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA Response.
Facchini G, D'Arienzo A, Nicastro A, Flauto F, Izzo M, Montella L, Riccardo F, Fusco GM, Trama F, Lauro GD, Costanzo GD, Tucci AG, Iasiello F, Di Lorenzo L, Maddaluno S, Liguori C, Cupillo RAD, Coppola P, Minissale A, Nardo MTD, Formisano L, Martinelli E, Ciappina G, Pisconti S, Berretta M, Barraco C. Facchini G, et al. Among authors: pisconti s. Cancers (Basel). 2025 Aug 5;17(15):2573. doi: 10.3390/cancers17152573. Cancers (Basel). 2025. PMID: 40805269 Free PMC article.
Integrating tissue and liquid biopsy comprehensive genomic profiling to predict efficacy of anti-EGFR therapies in metastatic colorectal cancer: Findings from the CAPRI-2 GOIM study.
Ciardiello D, Boscolo Bielo L, Napolitano S, Cioli E, Latiano TP, De Stefano A, Tamburini E, Ramundo M, Bordonaro R, Russo AE, Pisconti S, Nisi C, Lotesoriere C, Vallarelli S, Lonardi S, Barruca V, Cremolini C, Tortora G, Tagliaferri P, Pietrantonio F, Rosati G, Lucenti A, Scartozzi M, Brunetti O, Zampino MG, Zaniboni A, Berardi R, Paoletti G, Febbraro A, Martinelli E, Troiani T, Normanno N, Parente P, Fazio N, Curigliano G, De Vita F, Avallone A, Maiello E, Ciardiello F, Martini G. Ciardiello D, et al. Among authors: pisconti s. Eur J Cancer. 2025 Aug 26;226:115642. doi: 10.1016/j.ejca.2025.115642. Epub 2025 Jul 12. Eur J Cancer. 2025. PMID: 40669385 Clinical Trial.
120 results